- Home
- USAS vs COYA Comparison
USAS vs COYA Comparison
Compare USAS & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- COYA
- Stock Information
- Founded
- USAS 1998
- COYA 2020
- Country
- USAS Canada
- COYA United States
- Employees
- USAS N/A
- COYA N/A
- Industry
- USAS Metal Mining
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- COYA Health Care
- Exchange
- USAS Nasdaq
- COYA Nasdaq
- Market Cap
- USAS 122.4M
- COYA 104.3M
- IPO Year
- USAS N/A
- COYA 2022
- Fundamental
- Price
- USAS $0.40
- COYA $5.24
- Analyst Decision
- USAS Strong Buy
- COYA Strong Buy
- Analyst Count
- USAS 1
- COYA 4
- Target Price
- USAS $0.80
- COYA $16.25
- AVG Volume (30 Days)
- USAS 714.8K
- COYA 78.0K
- Earning Date
- USAS 11-07-2024
- COYA 11-06-2024
- Dividend Yield
- USAS N/A
- COYA N/A
- EPS Growth
- USAS N/A
- COYA N/A
- EPS
- USAS N/A
- COYA N/A
- Revenue
- USAS $97,123,000.00
- COYA $9,554,315.00
- Revenue This Year
- USAS $21.84
- COYA N/A
- Revenue Next Year
- USAS $46.00
- COYA $87.80
- P/E Ratio
- USAS N/A
- COYA N/A
- Revenue Growth
- USAS 14.33
- COYA N/A
- 52 Week Low
- USAS $0.20
- COYA $4.75
- 52 Week High
- USAS $0.54
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- USAS 52.20
- COYA 32.54
- Support Level
- USAS $0.35
- COYA $5.07
- Resistance Level
- USAS $0.44
- COYA $5.96
- Average True Range (ATR)
- USAS 0.03
- COYA 0.38
- MACD
- USAS -0.00
- COYA -0.06
- Stochastic Oscillator
- USAS 60.00
- COYA 12.45
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.